FLORENCE, S.C., Dec. 18, 2015 (GLOBE NEWSWIRE) -- DeGen Medical has received clearance from the FDA for our cervical interbody fusion device - Latitude-C™ Cervical Interbody Spacer System. Latitude-C™ Cervical Interbody Spacer offers the surgeon a wide variety of materials based on patient needs – PEEK-OPTIMA®, Porous Titanium with PEEK, PEEK-OPTIMA® HA Enhanced, Titanium and Carbon fiber-reinforced (CFR) PEEK-OPTIMA®.
|
|||||
The Latitude-C™ Cervical Interbody Spacer is unique, patent pending design considers the uncinate process of the cervical vertebra. The lateral angles of the Latitude-C™ cervical spacer device are unique to match individual patient anatomy and different angles allow for perfect fit at every fusion level.
"The Latitude-C™ graft is a tectonic shift away from traditional rectangular shape cervical grafts. The trapezoidal shape is tremendous improvement in respecting the correct anatomy of patients," says Dr.Chokshi at Pee Dee Spine Center, Florence, SC.
The Latitude-C™ Cervical Interbody fusion devices come in variety of shapes and sizes:
- 5 different footprints from 12x12mm to 20x15mm and each size has 10 heights - 5 to 14mm
- There are 3 different shape options to choose from – Anatomic, Lordotic and Parallel
- The system is delivered in several color coded options for procedural flexibility
The Latitude-C™ interbody fusion devices will be available in Q1 of 2016.
About DeGen Medical, Inc.
DeGen Medical, Inc. is a medical-device development company dedicated to providing surgeons with innovative products engineered to improve quality of life for patients with complex spinal disorders. World-class implants, coupled with intuitively-designed instrumentation, provide a complete package to promote superior surgical outcomes. Our passion to advance spine-care solutions is driven by clinical insights, sound research, and science-based design. DeGen Medical maintains the highest quality standards to provide reliable products and safeguard patient health.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38239
CONTACT: Jessica Clark
DeGen Medical, Inc.
Phone: 877-240-7838
www.DeGenmedical.com


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 



